GetTopicDetailResponse(id=f6144443e9d, topicName=頭頸部鱗癌, introduction=頭頸部鱗癌, content=null, image=null, comments=2, allHits=2163, url=https://h5.medsci.cn/topic?id=44437, type=1, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=24083, tagList=[TagDto(tagId=24083, tagName=頭頸部鱗癌)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2274384, encodeId=9ea122e4384fd, content=<a href='/topic/show?id=f6144443e9d' target=_blank style='color:#2F92EE;'>#頭頸部鱗癌#</a>, objectTitle=郭曄教授談頭頸腫瘤“加減法”：減手術(shù)、加免疫、去化療，有效提高患者生存治療, objectType=article, longId=887828, objectId=226788e82898, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240706/1720277147515_5579292.png, objectUrl=/article/show_article.do?id=226788e82898, replyNumber=0, likeNumber=16, createdTime=2025-07-22, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=226788e82898, moduleTitle=郭曄教授談頭頸腫瘤“加減法”：減手術(shù)、加免疫、去化療，有效提高患者生存治療, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=226788e82898)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=950227, encodeId=6f7f95022ed6, content=<a href='/topic/show?id=f6144443e9d' target=_blank style='color:#2F92EE;'>#頭頸部鱗癌#</a>口咽鱗狀細(xì)胞癌（OPSCC）的發(fā)病率在過去十年中急劇上升, objectTitle=Br J Cancer：放化療后HPV陽性口咽鱗狀細(xì)胞癌中向腸道微生物組轉(zhuǎn)變, objectType=article, longId=208295, objectId=0ec420829589, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2021311/1615476561346_2467676.PNG, objectUrl=/article/show_article.do?id=0ec420829589, replyNumber=0, likeNumber=149, createdTime=2021-03-22, rootId=0, userName=Nebula-Qin, userId=74c72110107, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0ec420829589, moduleTitle=Br J Cancer：放化療后HPV陽性口咽鱗狀細(xì)胞癌中向腸道微生物組轉(zhuǎn)變, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=0ec420829589)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=887508, encodeId=4b3988e50886, content=<a href='/topic/show?id=3fca4e359e3' target=_blank style='color:#2F92EE;'>#尼妥珠單抗#</a>聯(lián)合順鉑放療改善高<a href='/topic/show?id=e151882682' target=_blank style='color:#2F92EE;'>#HIF1α#</a>表達(dá)的局部晚期<a href='/topic/show?id=f6144443e9d' target=_blank style='color:#2F92EE;'>#頭頸部鱗癌#</a>患者的預(yù)后，難以理解。HIF1確實與血管新生有關(guān)，為什么不直接關(guān)注血管，以及VEGF表達(dá)？？, objectTitle=Br J Cancer：尼妥珠單抗聯(lián)合順鉑放療改善高HIF1α表達(dá)的局部晚期頭頸部鱗癌患者的預(yù)后, objectType=article, longId=201080, objectId=d88e20108084, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2020922/1600779365717_2467676.PNG, objectUrl=/article/show_article.do?id=d88e20108084, replyNumber=0, likeNumber=222, createdTime=2020-09-22, rootId=0, userName=lovetcm, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d88e20108084, moduleTitle=Br J Cancer：尼妥珠單抗聯(lián)合順鉑放療改善高HIF1α表達(dá)的局部晚期頭頸部鱗癌患者的預(yù)后, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=d88e20108084)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
